In their recent pre-print, not yet peer-reviewed, CITF Leadership Group member Dr. Gina Ogilvie, VSRG Working Group member Dr. Manish Sadarangani and colleagues in British Columbia explored COVID-19 vaccination intention among women and gender diverse individuals living with HIV.
A collaborative effort of over 150 scientists from over 20 countries, including CITF-funded researcher Dr. Donald Vinh from McGill University Health Centre and the Research Institute of the McGill University Health Centre, has led to the identification of a surprisingly high prevalence of a type of antibody that has been linked to fatal outcomes of COVID-19.
In a publication led by Dr. David Fisman from the University of Toronto in the Annals of Internal Medicine, CITF-funded researcher Dr. Sheila O’Brien and CITF Testing Working Party member Dr. Steven Drews, both from Canadian Blood Services, worked with colleagues from the University of Toronto and the University of Guelph and found that when accounting for testing rates, younger people in Ontario contracted SARS-CoV-2 more frequently than older people.
Investigators from the Canadian Immunization Research Network (CIRN), including CITF-funded researchers Drs. Jeffrey Kwong and Kumanan Wilson, provided epidemiological baseline rates of mortality and hospitalization to study COVID-19 outcomes in nursing home residents in Ontario.
Few studies have shown that immunocompromised individuals may mount attenuated antibody responses, compared to their otherwise healthy counterparts.
Along with colleagues, CITF Scientific Advisor Dr. Matthew Cheng and CITF-funded researcher Dr. Donald Vinh from McGill University and the RI-MUHC, have been studying the effectiveness and immunogenicity of the Made-in-Quebec, plant-based Medicago vaccine.
Organ transplant recipients often receive immunosuppressant drugs to avoid transplant rejection, but these compounds affect their ability to mount immunity effectively when vaccinated.
A recent commentary in Lancet Respiratory Medicine by CITF-funded researcher Dr. Margaret Herridge and colleagues highlights the record volume of COVID-19 patients treated for prolonged periods in Intensive Care Units (ICUs) around the world.
In this short perspective in Pediatric Transplantation, CITF-funded researcher Dr. Upton Allen and colleagues present the latest evidence regarding the impact of variants of concern (VOCs) in children with solid organ transplants.
COVID-19 has not affected all Canadian communities equally. A growing body of literature is highlighting the inequalities in communities with high rates of COVID-19.